HB 2302 — Pharmacist prescriptive auth
Last action — First reading, referred to Health Care & Wellness.
-
1Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill has been introduced in the House. Introduced January 12, 2026. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
Summary
Expanding prescriptive authority for pharmacists.
Bill Text
We don't have the full text on file for this bill yet.
Read HB 2302 on the official Washington source →Compared against the Revised Code of Washington as published AI-generated reading aid — verify against the official bill.
This bill amends 2 section(s) of the Revised Code of Washington: RCW 18.64.011; RCW 69.41.030.
-
RCW 18.64.011
a practitioner legally authorized to prescribe the medication for office use only; (c) The distribution of a drug product that has been compounded by a licensed pharmacy to other appropriately licensed entities under common ownership or control of the facility in which the compounding takes place; or (d) The delivery of finished and appropriately labeled compounded products dispensed pursuant to a valid prescription to alternate delivery locations, other than the patient's residence, when requested by the patient, or the prescriber to administer to the patient, or to another licensed pharmacy to dispense to the patient. (25) "Manufacturer" means a person, corporation, or other entity engaged in the manufacture of drugs or devices. (26) "Nonlegend" or "nonprescription" drugs means any drugs which may be lawfully sold without a prescription. (27) "Person" means an individual, corporation, government, governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other legal entity. (28) "Pharmacist" means a person duly licensed by the commission to engage in the practice of pharmacy. (29) "Pharmacy" means every place properly licensed by the commission where the practice of pharmacy is conducted. (30) "Plan of correction" means a proposal devised by the applicant or licensee that includes specific actions that must be taken to correct identified unresolved deficiencies with the time frames to complete them. (31) "Poison" does not include any article or mixture covered by the Washington pesticide control act (chapter 15.58 RCW), as enacted or hereafter amended. (32) "Practice of pharmacy" includes the practice of and responsibility for: Interpreting prescription orders; the compounding, dispensing, labeling, administering, and distributing of drugs and devices; the monitoring of drug therapy and use; the initiating or modifying of drug therapy in accordance with written guidelines or protocols previously established and approved for his or her practice by a practitioner authorized to prescribe drugs; diagnosing and the prescribing or ordering of drugs and devices based on his or her education, training, and experience;
amended
-
RCW 69.41.030
to the extent permitted by drug therapy guidelines or protocols established under RCW 18.64.011 and authorized by the commission and approved by a practitioner authorized to prescribe drugs→ podiatric physician and surgeon under chapter 18.22 RCW, a licensed midwife to the extent authorized under chapter 18.50 RCW, a veterinarian under chapter 18.92 RCW, a commissioned medical or dental officer in the United States armed forces or public health service in the discharge of his or her official duties, a duly licensed physician or dentist employed by the veterans administration in the discharge of his or her official duties, a registered nurse or advanced registered nurse practitioner under chapter 18.79 RCW when authorized by the board of nursing, a pharmacist licensed underamended
Action History
-
First reading, referred to Health Care & Wellness.
Sponsors
- (Thai) · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 150 not signed on
Sponsors (1)
- (Thai)
Co-sponsors (0)
None.
Not signed on (150)
150 members have not signed on to this bill.
Show all 150 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HB 2302 do?
- Expanding prescriptive authority for pharmacists.
- Who sponsors HB 2302?
- HB 2302 is sponsored by (Thai).
- What is the current status of HB 2302?
- This bill has been introduced in the House. Introduced January 12, 2026. It must pass committee before a floor vote.
- Where can I track HB 2302?
- Track HB 2302 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 2302
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 2302
Last checked for changes 4 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →